Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.
about
The rab11 effector protein FIP1 regulates adiponectin trafficking and secretionPPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerHuman but not mouse adipogenesis is critically dependent on LMO3SDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domainPhosphorylation of nuclear phospholipase C beta1 by extracellular signal-regulated kinase mediates the mitogenic action of insulin-like growth factor IMultiple ras downstream pathways mediate functional repression of the homeobox gene product TTF-1Extracellular signal-regulated kinase induces the megakaryocyte GPIIb/CD41 gene through MafB/KreislerThe transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signalingUp- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implicationPPARs and the cardiovascular systemReversine increases the plasticity of lineage-committed mammalian cellsSe-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitroAdipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51Nuclear receptors in bone physiology and diseasesThe alliance of mesenchymal stem cells, bone, and diabetesModulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modificationsPartial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone massPotential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional ActivityCytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascadePeroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genistein'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesAntitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gammap300 functions as a coactivator for the peroxisome proliferator-activated receptor alphaFKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathwayRequirement of fibroblast growth factor 10 in development of white adipose tissueAPC-dependent suppression of colon carcinogenesis by PPARgammaRegulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma functionUrsodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytesModulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferatorsDependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivationAnkrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblastsp300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectivelyDirect binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation.Characterization of the amino-terminal activation domain of peroxisome proliferator-activated receptor alpha. Importance of alpha-helical structure in the transactivating function.Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses AdipogenesisLow intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-Cot/Tpl2-MEK-ERK signaling pathwayNovel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.Autophagy is involved in adipogenic differentiation by repressesing proteasome-dependent PPARγ2 degradationAristolochia manshuriensis Kom inhibits adipocyte differentiation by regulation of ERK1/2 and Akt pathway.
P2860
Q21132508-28A18F89-56C3-4C45-ABDC-8A2D5A37C350Q21328702-59238064-0DA2-4172-82DB-6318B9DD0E81Q24297394-7A1E1DC0-5D46-4F11-AECA-149631F0A3ACQ24535573-4A6AB082-A643-4BB7-830D-B5A9ECA5DCB7Q24550973-19970D95-DDB4-4E74-8F59-332A245F99C0Q24554271-9DF300CD-12BE-411D-BB8A-A49C387ED1C8Q24567630-C4EFA264-EAFC-4B85-A9DF-BB530B22A308Q24628865-FF9D79E9-77D2-451A-9062-B850BC838729Q24633408-EDF4B478-2372-48E1-85A9-399B5A5D540FQ24642728-0D148488-0220-4F29-AEFA-2E20D32813FBQ24669793-4E1103A0-AD09-4B9B-8D01-943E27C3E808Q24813505-411953A2-131B-40A5-9C95-EAB1891960F6Q26785555-5A056840-A66B-4B02-8BE4-C21F41C32971Q26853017-BF8250F8-9679-4CE7-9EA6-E4FEF3AF1BAAQ27012497-C606B859-119E-44AD-B8F6-5E774BDD11BDQ27015807-D900C757-3372-43B7-89C6-B57ED2A791B7Q27334866-789360AA-15E5-4AA7-9177-E03D1E1A2CBCQ28066552-AA55E95A-7022-46AC-8F9C-6CD95AA28551Q28211233-5408E157-9DF4-45E8-81DE-B42A931A6778Q28214212-F2721508-F137-4FD1-9501-9638313EF46EQ28221639-A36FC7A1-AD25-4F2B-9B02-7DB6EB24FDB0Q28238709-ECA5545D-E5D6-4637-9888-B9132BF0A75CQ28251474-7E934913-F36B-4FB6-8F2B-0D4FB1FD2877Q28257373-0BE04038-1C48-4331-98B4-8BDA9AF66498Q28391433-DBDCF6AA-352F-405C-AD8B-3AFA0A6A0100Q28504753-97F65A8B-775E-48E2-B727-C9141767503FQ28506424-8ABE9843-7C58-4FD8-80FC-3C9E15B9DFD6Q28508365-2DA12F1A-7F9E-4E08-AF9F-220CBFF344BFQ28535795-7A85762C-D46A-447A-ACF0-AFA66086295EQ28564380-43F032EB-D8F3-41AE-AD64-66E78A203931Q28580795-130C5715-DB14-441E-A00B-E7431B5E2817Q28588194-A5161478-B4C8-48DE-BCBB-CC13DC06B97DQ28609750-9E71892E-E03C-4AAE-A870-C146927710ABQ30168727-33CC4D64-4A18-4E89-B27E-8C977D0CB29EQ30323774-E6667BDB-F2A8-4ABF-950F-EAF71261A47CQ30388166-ADF16465-3988-44E1-9290-18CBE925C574Q30414463-C4E7E80C-0635-46EC-8A49-CDF94205E5CBQ30453600-F425E8F5-AD0E-4F7C-B2A5-6AA70270277BQ30456765-2069AB33-9903-4FEA-9742-EA1D22E8BB5CQ31107164-E1140B31-F0F5-48B7-8038-DF552EA93F59
P2860
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.
@en
type
label
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.
@en
prefLabel
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.
@en
P2093
P1433
P1476
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.
@en
P2093
P304
P356
10.1126/SCIENCE.274.5295.2100
P407
P577
1996-12-01T00:00:00Z